This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Reply to “Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety

Shaila Misri, MD; Pratibha Reebye, MD; Maria Corral, MD; and Lisa Milis, BA

Published: November 15, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We appreciate the response of Ms. McClendon to our articleon paroxetine and cognitive-behavioral therapy (CBT) inthe treatment of comorbid postpartum depression and anxiety.We agree that our findings are from women with severe comorbiddepression and anxiety, as indicated by their Hamilton RatingScale for Depression and Hamilton Rating Scale for Anxietyscores at baseline, and are therefore representative of only thisselect population. Due to the relative lack of research on theclinical effectiveness of combined pharmacologic and psychologicalinterventions for postpartum depression and anxiety, theprimary aim of the study was to provide readers with preliminaryinformation on this subject taken from a select sampletreated at a tertiary hospital outpatient clinic.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 66

Quick Links: Depression (MDD)